The restoration of insulin signaling in the brain through intranasal insulin administration or conventional oral drug delivery is currently under investigation as a potential therapeutic approach for enhancing insulin sensitivity in the treatment of AD.177. The gene discussed is INS; the disease is Alzheimer disease.